GB INF 001
Alternative Names: GB-INF-001Latest Information Update: 30 May 2025
At a glance
- Originator GATBIO
- Class Antivirals; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 30 May 2025 Early research in COVID-2019 infections in Spain (unspecified route), before May 2025 (GATBIO pipeline, May 2025)